EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease

Víctor Sebastián-Pérez iD, María Jimena Martínez iD, Carmen Gil iD, Nuria Eugenia Campillo iD, Ana Martínez iD, Ignacio Ponzoni iD

Journal of Integrative Bioinformatics · 25.02.2019 · 16 (1)

DOI: 10.1515/jib-2018-0063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Bioinformatics, online erschienen am 14.02.2019. Verfasst von Víctor Sebastián-Pérez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Biológicas (CIB-CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Models, Molecular, Quantitative Structure-Activity Relationship. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONICET, UNS, MECD, VSP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease is one of the most common neurodegenerative illnesses in older persons and the leucine-rich repeat kinase 2 (LRRK2) is an auspicious target for its pharmacological treatment. In this work, quantitative structure–activity relationship (QSAR) models for identification of putative inhibitors of LRRK2 protein are developed by using an in-house chemical library and several machine learning techniques. The methodology applied in this paper has two steps: first, alternative subsets of molecular descriptors useful for characterizing LRRK2 inhibitors are chosen by a multi-objective feature selection method; secondly, QSAR models are learned by using these subsets and three different strategies for supervised learning. The qualities of all these QSAR models are compared by classical metrics and the best models are discussed in statistical and physicochemical terms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, MolecularQuantitative Structure-Activity RelationshipComputer SimulationHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Molecular StructureParkinson DiseaseProtein Kinase Inhibitors

Stichwörter der Autor:innen

CheminformaticsLRRK2Machine LearningParkinson’s diseaseQSAR

Substanzen

Protein Kinase InhibitorsLRRK2 protein, humanLeucine-Rich Repeat Serine-Threonine Protein Kinase-2

Autor:innen und Institutionen

  • Centro de Investigaciones Biológicas (CIB-CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain.
  • Instituto de Ciencias e Ingeniería de la Computación (UNS-CONICET), Departamento de Ciencias e Ingeniería de la Computación, Universidad Nacional del Sur (UNS), Bahía Blanca, Argentina.

ORCID-Profile: Víctor Sebastián-Pérez, María Jimena Martínez, Carmen Gil, Nuria Eugenia Campillo, Ana Martínez, Ignacio Ponzoni

Förderung

  • CONICET
  • UNS
  • MECD, VSP
  • Banco Santander

Zitieren

APA

Sebastián-Pérez, V., Martínez, M. J., Gil, C., Campillo, N. E., Martínez, A., & Ponzoni, I. (2019). QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease. Journal of Integrative Bioinformatics, 16(1). https://doi.org/10.1515/jib-2018-0063

Vancouver

Sebastián-Pérez V, Martínez MJ, Gil C, Campillo NE, Martínez A, Ponzoni I. QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease. Journal of Integrative Bioinformatics. 2019;16(1). doi:10.1515/jib-2018-0063

BibTeX
@article{SebastinPrez2019,
  author = {Sebastián-Pérez, Víctor and Martínez, María Jimena and Gil, Carmen and Campillo, Nuria Eugenia and Martínez, Ana and Ponzoni, Ignacio},
  title = {QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease},
  journal = {Journal of Integrative Bioinformatics},
  year = {2019},
  volume = {16},
  number = {1},
  doi = {10.1515/jib-2018-0063}
}
Kostenlos starten →